The Most Favored Nation Policy: early insights into Europe’s response
On 12 May 2025, US President Donald Trump signed an executive order directing the US Department of Health and Human…
Pricing and Market Access
GlobalData’s key thoughts from World EPA Congress 2026
Market instability expected from South Korea’s new pricing reform in 2026-2028
Have originator medicines’ list prices started to drop in the US?
Transformative arrival of oral weight loss medicines in the US
US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy
China releases 2025 NRDL and first commercial insurance drug list
Win for pharma in UK – zero US tariffs, VPAG rate cap and NICE threshold increase
